Catherine Skari

Pain Impact and Management in Individuals With Transfusion-Dependent Thalassaemia

Over the last several decades, there has been significant progress in addressing the main symptoms and related health issues of…

Read More »

ELEVATING AWARENESS | 29 February Is Rare Disease Day

Rare Disease Day is the globally-coordinated movement on rare diseases, working towards equity in social opportunity, healthcare, and access to…

Read More »

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | Ruxoprubart Scores FDA Orphan Drug Designation for PNH Treatment

FDA’s recognition of Ruxoprubart as an orphan drug for PNH underscores its potential to fulfill a crucial need for individuals…

Read More »

BREAKING NEWS | TIF’s Collaboration with WHO Extended to 2027

Our enduring collaboration was newly endorsed by WHO’s Executive Board at its 154th session in January 2024, demonstrating our significant…

Read More »

APLASTIC ANEMIA | Incidence and Clinical Management in Spain Consistent with Other Studies

The study was carried out through a multicenter, ambispective, observational approach encompassing 7 Spanish hospitals, catering to roughly 3.91 million…

Read More »

ADVOCACY IN ACTION | Highlights from the TIF Meeting with Greek Health Minister, Adonis Georgiadis

A productive meeting between the Greek Minister of Health, Mr. Adonis Georgiades, and a Thalassaemia International Federation (TIF) delegation took…

Read More »

TIF INTERNATIONAL CONFERENCE | 3-5 November 2023

Inside the Conference The 16th International Conference on Thalassaemia and Other Haemoglobinopathies, jointly organised with the 18th TIF Conference for…

Read More »

NEW WAVE OF LEADERSHIP | WHO Appoints Regional Directors for Eastern Mediterranean, South-East Asia, and Western Pacific Regions

These influential professionals were selected by Regional Committees and confirmed by the Executive Board. Beginning their roles on 1st February…

Read More »

LentiGlobin Administration to Sickle Cell Disease Patients: Effect on Serum Markers and Vaso-Occlusive Crisis

LentiGlobin, an innovative gene therapy, introduces a modified beta-globin gene that yields an anti-sickling hemoglobin variant. It boosts total hemoglobin…

Read More »

‘Phenoconversion’ in Adult Patients with β-Thalassemia

Rate and risk factors for phenoconversion from non-transfusion-dependent β-thalassemia (NTDT) to transfusion-dependent β-thalassemia (TDT) during a 10-year follow up of…

Read More »